Word

VYRIAD

Status

Pending

Status Code

641

Status Date

Wednesday, April 10, 2024

Serial Number

98122765

Mark Type

4000

Filing Date

Tuesday, August 8, 2023

Trademark Owner History

Vyriad, Inc.

Classifications

5 Pharmaceuticals, namely, bio-pharmaceuticals for the treatment of cancer; stem cells for medical use; medicinal preparations for the treatment of infectious diseases and for use in oncology; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for providing stem cell therapy; cellular pharmaceutical preparations for use in oncology and cardio-vascular diseases; living tissue in the nature of chimeric antigen receptor (CAR-T) cells for medical use; pharmaceutical preparations for use in oncology

44 Cancer treatment medical services; oncolytic virotherapy medical services; stem cell therapy services; medical services in the field of oncology; medical services, namely, cellular immunotherapy treatments utilizing chimeric antigen receptor T-cells for use in treating disease, namely, the treatment of cancer

42 Medical and scientific research and development in the fields of cancer treatment and oncolytic virotherapy; research and development of bio-pharmaceuticals for the treatment of cancer; medical and scientific research in the fields of genetics and oncology; research and development of technology in the fields of stem cells and stem cell therapy; development of therapeutics and cell therapies; scientific research and development of cell therapies, namely, chimeric antigen receptor T-cells (CAR-T) to cure solid tumor cancers and other cancers; medical and scientific research services in the fields of genetics, cell therapy, oncology, immuno-oncology

Trademark Events

Apr 10, 2024

Notification Of Non-Final Action E-Mailed

Apr 10, 2024

Non-Final Action E-Mailed

Apr 10, 2024

Non-Final Action Written

Apr 8, 2024

Assigned To Examiner

Sep 8, 2023

New Application Office Supplied Data Entered

Aug 11, 2023

New Application Entered